EP2806877
Taugavirkar sterasamsetningar sem innihalda klósamband af allópregnanólóni og súlfóbútýleter beta-sýklódextríni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
23.1.2013EP published:
9.10.2019EP application number:
13740743.3
EP translation filed:
9.12.2019Grant published:
15.1.2020EPO information:
European Patent Register
Max expiry date:
22.1.2033Expiry date:
22.1.2026Next due date:
31.1.2026
Title:
NEUROACTIVE STEROID FORMULATIONS COMPRISING A COMPLEX OF ALLOPREGNANOLONE AND SULFOBUTYL ETHER BETA-CYCLODEXTRIN
Timeline
Today
23.1.2013EP application
9.10.2019EP Publication
9.12.2019Translation submitted
15.1.2020Registration published
22.1.2026Expires
Owner
Name:
Sage Therapeutics, Inc.Address:
215 First Street, 02142, Cambridge, MA, US
Inventor
Name:
REDDY, KiranAddress:
Cambridge, MA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261589740 PDate:
23.1.2012Country:
US
Classification
Categories:
A61K 31/57, A61K 47/69, A61P 25/00, A61P 25/08
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 31.1.2020
Expires: 22.1.2021
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 29.12.2020
Expires: 22.1.2022
Payer: Árnason Faktor ehf.
Number: 10
Paid: 7.12.2021
Expires: 22.1.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 13.12.2022
Expires: 22.1.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 18.12.2023
Expires: 22.1.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 13.1.2025
Expires: 22.1.2026
Payer: Árnason Faktor ehf.